Dexmedetomidine in Bariatric Surgery: A Systematic Review and Meta-Analysis of Its Effects on Postoperative Pain and Postoperative Nausea and Vomiting
Journal of Clinical Medicine · 21.01.2025 · 14 (3) · 679
DOI: 10.3390/jcm14030679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.01.2025. Verfasst von Reem Altamimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 14256, Saudi Arabia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Bariatric surgery is associated with significant postoperative challenges, including pain and nausea. Dexmedetomidine (Dex), an alpha-2 adrenergic agonist, is commonly used to manage pain and postoperative nausea and vomiting (PONV) in various surgical settings. This meta-analysis evaluates the efficacy of Dex in bariatric surgery patients, focusing on postoperative pain intensity, opioid consumption, and PONV.
Methods
We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) published between 2010 and 2023, assessing Dex use during or after bariatric surgery. Studies comparing Dex to placebo or standard care were included. Data extraction was performed independently by two reviewers, and statistical analysis was conducted using a random-effects model. Study quality was assessed using the Cochrane Risk of Bias tool.
Results
Six RCTs (485 participants) met the inclusion criteria. Dex significantly reduced intraoperative fentanyl use (SMD −1.33, 95% CI [−2.19, −0.47], p = 0.002). Pain scores showed mixed results, with some studies reporting lower pain intensity in the Dex group, while others found no significant difference compared to morphine or placebo. PONV scores were generally lower in the Dex group (p = 0.01) compared to placebo and morphine. No significant differences were found in morphine consumption (SMD −1.13, 95% CI [−2.24, 0.01], p = 0.05) or recovery time.
Conclusions
Dexmedetomidine appears to reduce opioid requirements and postoperative nausea in bariatric surgery patients. However, the variability in pain management outcomes suggests that further well-designed RCTs are needed to confirm its overall efficacy. The findings are based on moderate-quality evidence, and further research should aim to standardize dosing protocols and patient populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 14256, Saudi Arabia.
- College of Medicine, Taibah University, Medina 42361, Saudi Arabia.
- Department of Health Sciences, King Saud bin Abdulaziz University, Riyadh 11481, Saudi Arabia.
- Ministry of National Guard Health Affairs, Riyadh 11426, Saudi Arabia.
ORCID-Profile: Reem Altamimi, Danah Alnajjar, Rawan Bin Salamah, Abdulaziz Alghamdi
Zitieren
APA
Altamimi, R., Alnajjar, D., Bin Salamah, R., Mandoorah, J., Alghamdi, A., Aloteibi, R. E., Almusharaf, L., & Albabtain, B. (2025). Dexmedetomidine in Bariatric Surgery: A Systematic Review and Meta-Analysis of Its Effects on Postoperative Pain and Postoperative Nausea and Vomiting. Journal of Clinical Medicine, 14(3), 679. https://doi.org/10.3390/jcm14030679
Vancouver
Altamimi R, Alnajjar D, Bin Salamah R, Mandoorah J, Alghamdi A, Aloteibi RE, et al. Dexmedetomidine in Bariatric Surgery: A Systematic Review and Meta-Analysis of Its Effects on Postoperative Pain and Postoperative Nausea and Vomiting. Journal of Clinical Medicine. 2025;14(3):679. doi:10.3390/jcm14030679
BibTeX
@article{Altamimi2025,
author = {Altamimi, Reem and Alnajjar, Danah and Bin Salamah, Rawan and Mandoorah, Joana and Alghamdi, Abdulaziz and Aloteibi, Reema E and Almusharaf, Lamya and Albabtain, Bader},
title = {Dexmedetomidine in Bariatric Surgery: A Systematic Review and Meta-Analysis of Its Effects on Postoperative Pain and Postoperative Nausea and Vomiting},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {3},
pages = {679},
doi = {10.3390/jcm14030679}
}
EUVIMED